ADA	American Diabetes Association
AEs	Adverse events
AUC	Area under the curve
BCS	Biopharmaceutical Classification System
BMI	Body mass index
CI	Confidence interval
Cmax	Peak plasma concentration
COFEPRIS	Mexican Ministry of Health
CRO	Contract research organization
ECG	Electrocardiogram
IR	Immediate release
ITT	Intention-to-treat
Ke	Terminal elimination rate constant
LL	Lower limit
NCA	Non-compartmental analysis
PK	Pharmacokinetics
PP	Per-protocol
RLD	Reference listed drug
SGLT2	Sodium–glucose cotransporter 2
SD	Standard deviation
t1/2	Elimination half-life
tmax	Time to reach peak plasma concentration
T2D	Type 2 diabetes
UL	Upper limit